← back to search

David O’Reilly

Cardiff and Vale University Health Board ·
Area of research
Hepatology · Political Science and International Relations
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Commonwealth, Australian Politics and Federalism, Colorectal Cancer Treatments and Studies, and Australian History and Society.
h-index
17
citations
1,330
works
143
NIH funding
primary concept
email

Recent publications

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Journal for ImmunoTherapy of Cancer 2025cited by 20position: middledoi
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry
Journal for ImmunoTherapy of Cancer 2025cited by 2position: middledoi
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity
Lung Cancer 2025cited by 1position: middledoi
Treatment Decisions for Resectable Non–Small-Cell Lung Cancer: Balancing Less With More?
American Society of Clinical Oncology Educational Book 2023cited by 23position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

C. Le Péchoux · Institut Gustave Roussy1 papers (2023–2023)Jessica Donington · Twitter (United States)1 papers (2023–2023)Simon T. Barry · AstraZeneca (United Kingdom)1 papers (2023–2023)Jarushka Naidoo · Johns Hopkins Bayview Medical Center1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023)